Home
CLNN
CLNN News

Latest Clene Inc. (CLNN) News on November 21, 2024

Clene price target lowered to $83 from $86 at Canaccord

TipRanks

6 days ago

Clene price target lowered to $83 from $86 at Canaccord

Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights

GlobeNewswire

8 days ago

Clene Reports Third Quarter 2024 Financial Results and Recent Operating Highlights

IBN Coverage: Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker With FDA Leadership

NewMediaWire

a month ago

IBN Coverage: Clene (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker With FDA Leadership

IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences

NewMediaWire

a month ago

IBN Coverage: Clene (NASDAQ: CLNN) Presents Lead Candidate CNM-Au8(R) Updates at Investor Conferences

IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements

NewMediaWire

a month ago

IBN Coverage: Clene (NASDAQ: CLNN) Closes $7.3M Registered Direct Offering and Concurrent Private Placements

IBN Coverage: Clene (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences

NewMediaWire

a month ago

IBN Coverage: Clene (NASDAQ: CLNN) Announces Participation at Two Upcoming Investor Conferences

Clene to Present at Upcoming October Conferences

GlobeNewswire

a month ago

Clene to Present at Upcoming October Conferences

Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares

Simply Wall St.

2 months ago

Independent Chairman of the Board of Clene David Matlin Buys 26% More Shares

IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M

NewMediaWire

2 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Closes on Direct Offering, Concurrent Private Placements Totaling $7.3M

IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements

NewMediaWire

2 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Announces Series of Direct Offerings, Concurrent Private Placements

Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility

GlobeNewswire

2 months ago

Clene Announces Closing of $7.3 Million Registered Direct Offering and Concurrent Private Placements and Amendment of Debt Facility

Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules

GlobeNewswire

2 months ago

Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules

IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership

NewMediaWire

2 months ago

IBN Coverage: Clene (NASDAQ: CLNN) to Discuss CNM-Au8(R) Data FDA Leadership

Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data

GlobeNewswire

2 months ago

Clene Granted In-Person Meeting With FDA Senior Leadership to Discuss CNM-Au8 Biomarker and Related Clinical and Survival Data

IBN Coverage: Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Management to Present at H.C. Wainwright Investment Conference

IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Positioned as Leader in Addressing Neurodegenerative Diseases

Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire

3 months ago

Clene to Present at the H.C. Wainwright 26th Annual Global Investment Conference

IBN Coverage: Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) CEO Discusses CNM-Au8(R) Trial Results on BioMedWire Podcast

IBN Coverage: Clene's (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials

NewMediaWire

3 months ago

IBN Coverage: Clene's (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers, Long-term Survival in ALS Trials

IBN Coverage: Clene (NASDAQ: CLNN) Makes Strides in Developing CNM-Au8(R) to Address Neurodegenerative Conditions

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Makes Strides in Developing CNM-Au8(R) to Address Neurodegenerative Conditions

IBN Coverage: Clene (NASDAQ: CLNN) CEO Spotlighted in Recent BioMedWire Podcast Episode

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) CEO Spotlighted in Recent BioMedWire Podcast Episode

IBN Coverage: Clene (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

NewMediaWire

3 months ago

IBN Coverage: Clene (NASDAQ: CLNN) Releases Q2 2024 Financial Results, Provides Updates

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

GlobeNewswire

3 months ago

IBN Announces Latest Episode of The BioMedWire Podcast featuring Rob Etherington, CEO of Clene Inc.

Clene Reports Second Quarter 2024 Financial Results and Recent Operating Highlights

GlobeNewswire

3 months ago

Clene Reports Second Quarter 2024 Financial Results and Recent Operating Highlights

Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS

GlobeNewswire

3 months ago

Clene Announces New CNM-Au8® Biomarker and Clinical Efficacy Data Submitted to FDA In Support of Treatment For ALS

Clene to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

GlobeNewswire

4 months ago

Clene to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

GlobeNewswire

4 months ago

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now

Clene to Present at the Emerging Growth Conference

GlobeNewswire

4 months ago

Clene to Present at the Emerging Growth Conference

Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA Feedback on Potential Pathway to Accelerated Approval for CNM-Au8® in ALS

GlobeNewswire

4 months ago

Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA Feedback on Potential Pathway to Accelerated Approval for CNM-Au8® in ALS

Clene Announces 1-for-20 Reverse Stock Split

GlobeNewswire

4 months ago

Clene Announces 1-for-20 Reverse Stock Split

Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference

GlobeNewswire

5 months ago

Clene to Present at H.C. Wainwright’s 5th Annual Neuro Perspectives Virtual Conference

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome

GlobeNewswire

5 months ago

Clene Presents Preliminary Data for CNM-Au8® as a Potential Treatment for Rett Syndrome

Clene Presents Extended Survival Data Through 3.5 Years and New NfL Responder Results with CNM-Au8® 30 mg Treatment from the HEALEY ALS Platform Trial Open Label Extension at the 2024 ENCALS Meeting

GlobeNewswire

5 months ago

Clene Presents Extended Survival Data Through 3.5 Years and New NfL Responder Results with CNM-Au8® 30 mg Treatment from the HEALEY ALS Platform Trial Open Label Extension at the 2024 ENCALS Meeting

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

GlobeNewswire

5 months ago

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

Better AI Stock: Palantir vs. Snowflake

Motley Fool

5 months ago

Better AI Stock: Palantir vs. Snowflake

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

Motley Fool

5 months ago

Is Now the Time to Buy 3 of the S&P 500's Highest-Yielding Dividend Stocks?

BigBear.ai Stock: Buy, Sell, or Hold?

Motley Fool

5 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'

AFP

5 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?

Motley Fool

5 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

GuruFocus.com

5 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

GuruFocus.com

5 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Simply Wall St.

5 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Clene to Present at the Emerging Growth Conference

GlobeNewswire

6 months ago

Clene to Present at the Emerging Growth Conference

Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)

GlobeNewswire

6 months ago

Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)

Clene to Present at Upcoming May Conferences

GlobeNewswire

6 months ago

Clene to Present at Upcoming May Conferences

Clene First Quarter 2024 Earnings: Misses Expectations

Simply Wall St.

6 months ago

Clene First Quarter 2024 Earnings: Misses Expectations

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

GlobeNewswire

6 months ago

Clene Reports First Quarter 2024 Financial Results and Recent Operating Highlights

IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington

GlobeNewswire

7 months ago

IBN Announces From Lab to Launch Podcast Featuring Clene Inc. CEO Rob Etherington

Bullish Clene Insiders Loaded Up On US$9.58m Of Stock

Simply Wall St.

7 months ago

Bullish Clene Insiders Loaded Up On US$9.58m Of Stock

Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting

GlobeNewswire

7 months ago

Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting

IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

GlobeNewswire

8 months ago

IBN Announces First in Human Podcast Featuring Clene Inc. CEO Rob Etherington

Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

GlobeNewswire

8 months ago

Clene Announces Peer-Reviewed Publication Characterizing the Protein Corona of the Investigational Neurodegenerative Disease Drug, CNM-Au8®

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

GlobeNewswire

8 months ago

Clene Reports Full Year 2023 Financial Results and Recent Operating Highlights

Clene to Present at the 36th Annual ROTH Conference

GlobeNewswire

8 months ago

Clene to Present at the 36th Annual ROTH Conference

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024

GlobeNewswire

9 months ago

Clene Presents Clinical Results of CNM-Au8® 30mg Treatment From Visionary-MS Trial Long-Term Extension at Annual ACTRIMS Forum 2024

Clene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use Programs

GlobeNewswire

9 months ago

Clene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use Programs

Clene Inc. announces positive results from CNM-Au8 results from MS trial

News Direct

10 months ago

Clene Inc. announces positive results from CNM-Au8 results from MS trial

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

Business Wire

10 months ago

Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024

TEAF Announces 2023 Fund Tax Characterization of Distributions, Release of Annual Report

ACCESSWIRE

10 months ago

TEAF Announces 2023 Fund Tax Characterization of Distributions, Release of Annual Report

Princeton Bancorp (BPRN) Q4 Earnings Surpass Estimates

Zacks

10 months ago

Princeton Bancorp (BPRN) Q4 Earnings Surpass Estimates

Inogen Names Michael Bourque as New Chief Financial Officer

Business Wire

10 months ago

Inogen Names Michael Bourque as New Chief Financial Officer

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

NewMediaWire

10 months ago

Clene VISIONARY-MS Trial Data May Support CNM-Au8(R) as MS Treatment

Delcath Systems, Inc. (NASDAQ:DCTH): Are Analysts Optimistic?

Simply Wall St.

10 months ago

Delcath Systems, Inc. (NASDAQ:DCTH): Are Analysts Optimistic?

Trump Shakes Iowa: Discover the 3 Hot Stocks Set to Soar in His Wake

Benzinga

10 months ago

Trump Shakes Iowa: Discover the 3 Hot Stocks Set to Soar in His Wake

American Battery Technology Company Announces Increased and Upgraded Lithium Resource to Measured and Indicated Classifications for One of the Largest Lithium Projects in the United States

PR Newswire

10 months ago

American Battery Technology Company Announces Increased and Upgraded Lithium Resource to Measured and Indicated Classifications for One of the Largest Lithium Projects in the United States

Nutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insiders

Simply Wall St.

10 months ago

Nutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insiders

RADCOM to Report Fourth Quarter and Full Year 2023 Results on January 31, 2024

PR Newswire

10 months ago

RADCOM to Report Fourth Quarter and Full Year 2023 Results on January 31, 2024

Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program

GlobeNewswire

10 months ago

Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program

Clene Announces Significant Positive Results from LTE VISIONARY-MS Trial

NewMediaWire

10 months ago

Clene Announces Significant Positive Results from LTE VISIONARY-MS Trial

Clene Reports Significant Improvement in Vision and Cognition With CNM-Au8® Treatment in VISIONARY-MS Trial Long-Term Open Label Extension

GlobeNewswire

10 months ago

Clene Reports Significant Improvement in Vision and Cognition With CNM-Au8® Treatment in VISIONARY-MS Trial Long-Term Open Label Extension

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

ACCESSWIRE

10 months ago

Clough Global Equity Fund Declares Monthly Cash Distributions For January, February, and March 2024 of $0.0603 Per Share

Business Wire

a year ago

Coya Therapeutics Announces Successful Pre-IND and Type C Meetings with the FDA to Advance the Development of COYA 302 for Treatment of Amyotrophic Lateral Sclerosis (ALS)

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

GlobeNewswire

a year ago

Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones

Clene's Phase 2 REPAIR-PD and REPAIR-MD Trials Support Advancement to Phase 3

NewMediaWire

a year ago

Clene's Phase 2 REPAIR-PD and REPAIR-MD Trials Support Advancement to Phase 3

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

ACCESSWIRE

a year ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Simply Wall St.

a year ago

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

AMTD Movie "Goldfinger" will be Globally Released tomorrow across U.S., Canada, U.K., Australia, New Zealand, and major cities across Asia

Business Wire

a year ago

AMTD Movie "Goldfinger" will be Globally Released tomorrow across U.S., Canada, U.K., Australia, New Zealand, and major cities across Asia

Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain

Business Wire

a year ago

Vistagen Receives Notice from European Patent Office of Intention to Grant Patent for AV-101 to Treat Neuropathic Pain

GlobeNewswire

a year ago

Embrace Change Acquisition Corp. Receives Nasdaq Notice Regarding Late Form 10-Q Filing

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

The Fly

a year ago

Karuna downgraded, Arm target raised: Wall Street's top analyst calls

Live Ventures Incorporated (NASDAQ:LIVE) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

Live Ventures Incorporated (NASDAQ:LIVE) Q4 2023 Earnings Call Transcript

Clene Announces New Data from HEALEY ALS Platform Trial

NewMediaWire

a year ago

Clene Announces New Data from HEALEY ALS Platform Trial

Clene Provides Update on ALS Clinical Development Meeting With FDA

GlobeNewswire

a year ago

Clene Provides Update on ALS Clinical Development Meeting With FDA

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension

GlobeNewswire

a year ago

Clene Reports Reduction in Biomarker Plasma Neurofilament Light (NfL) Levels and Improved Survival With CNM-Au8® Treatment From HEALEY ALS Platform Trial Long-Term Open Label Extension

Business Wire

a year ago

Mr. Wilbur L. Ross, Former United States Secretary of Commerce, Joins Board of Coya Therapeutics, Inc.

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

NewMediaWire

a year ago

How Clene CNM-Au8(R) Takes Advantage of Gold Nanocrystals to Target Neurodegenerative Disorders

Executive VP and CFO Robert Anderson Buys 8,750 Shares of USCB Financial Holdings Inc

GuruFocus.com

a year ago

Executive VP and CFO Robert Anderson Buys 8,750 Shares of USCB Financial Holdings Inc

Inotiv, Inc. (NOTV) Shows Fast-paced Momentum But Is Still a Bargain Stock

Zacks

a year ago

Inotiv, Inc. (NOTV) Shows Fast-paced Momentum But Is Still a Bargain Stock

David Einhorn's Greenlight Capital Adds Coya Therapeutics to Its Portfolio

GuruFocus.com

a year ago

David Einhorn's Greenlight Capital Adds Coya Therapeutics to Its Portfolio

Turtle Beach Unveils Its Groundbreaking VelocityOne Flightdeck – the Ultimate Universal HOTAS Flight Simulation Control System

Business Wire

a year ago

Turtle Beach Unveils Its Groundbreaking VelocityOne Flightdeck – the Ultimate Universal HOTAS Flight Simulation Control System

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

InvestorPlace

a year ago

3 Off-the-Beaten-Path Stocks Poised for Substantial Growth

Associated Press Finance

a year ago

Frequency Electronics: Fiscal Q2 Earnings Snapshot

GlobeNewswire

a year ago

Frequency Electronics, Inc. Announces Second Quarter and Fiscal Year 2024 Financial Results

Syntec Optics Expands Thin-Film Technology with Gold Coating Capabilities (Nasdaq: OPTX)

GlobeNewswire

a year ago

Syntec Optics Expands Thin-Film Technology with Gold Coating Capabilities (Nasdaq: OPTX)

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders

Simply Wall St.

a year ago

Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) top owners are individual investors with 55% stake, while 45% is held by insiders

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is Atossa Genetics (ATOS) Outperforming Other Medical Stocks This Year?

GlobeNewswire

a year ago

Frequency Electronics Announces 2nd Quarter Financial Results Conference Call: Tuesday December 12, 2023, at 4:30 PM ET

Pegasus Digital Mobility Acquisition Corp. Announces the Results of its Extraordinary General Meeting and Amendment of its Memorandum and Articles of Association

Business Wire

a year ago

Pegasus Digital Mobility Acquisition Corp. Announces the Results of its Extraordinary General Meeting and Amendment of its Memorandum and Articles of Association

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like XBiotech (NASDAQ:XBIT) Are In A Position To Invest In Growth

Share on Social Networks: